VENEZIANI, BIANCA MARIA
 Distribuzione geografica
Continente #
AS - Asia 3.893
NA - Nord America 3.642
EU - Europa 2.988
SA - Sud America 403
AF - Africa 84
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 3
Totale 11.017
Nazione #
US - Stati Uniti d'America 3.463
SG - Singapore 1.843
RU - Federazione Russa 1.174
CN - Cina 708
IT - Italia 699
VN - Vietnam 634
BR - Brasile 339
HK - Hong Kong 324
FR - Francia 272
DE - Germania 211
FI - Finlandia 153
CA - Canada 120
NL - Olanda 116
IE - Irlanda 111
UA - Ucraina 87
BD - Bangladesh 83
IN - India 77
GB - Regno Unito 71
JP - Giappone 52
CI - Costa d'Avorio 33
MX - Messico 33
SE - Svezia 29
AR - Argentina 25
IQ - Iraq 21
ZA - Sudafrica 21
PH - Filippine 18
PL - Polonia 18
ID - Indonesia 17
KR - Corea 14
TH - Thailandia 14
PK - Pakistan 12
ES - Italia 11
VE - Venezuela 11
UZ - Uzbekistan 9
NP - Nepal 8
TR - Turchia 8
CO - Colombia 7
AT - Austria 6
EC - Ecuador 6
IL - Israele 6
JM - Giamaica 6
PY - Paraguay 6
SA - Arabia Saudita 6
TW - Taiwan 6
AZ - Azerbaigian 5
BE - Belgio 5
EG - Egitto 5
JO - Giordania 5
LT - Lituania 5
CL - Cile 4
IR - Iran 4
PT - Portogallo 4
TN - Tunisia 4
AU - Australia 3
ET - Etiopia 3
GT - Guatemala 3
KG - Kirghizistan 3
MA - Marocco 3
MK - Macedonia 3
PA - Panama 3
PE - Perù 3
BB - Barbados 2
BG - Bulgaria 2
BO - Bolivia 2
CR - Costa Rica 2
DJ - Gibuti 2
DZ - Algeria 2
HN - Honduras 2
HR - Croazia 2
KE - Kenya 2
KZ - Kazakistan 2
LB - Libano 2
MY - Malesia 2
QA - Qatar 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
UG - Uganda 2
XK - ???statistics.table.value.countryCode.XK??? 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AO - Angola 1
AP - ???statistics.table.value.countryCode.AP??? 1
BJ - Benin 1
BS - Bahamas 1
BW - Botswana 1
BY - Bielorussia 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
GE - Georgia 1
LA - Repubblica Popolare Democratica del Laos 1
LC - Santa Lucia 1
LY - Libia 1
MN - Mongolia 1
NC - Nuova Caledonia 1
NG - Nigeria 1
NI - Nicaragua 1
OM - Oman 1
PR - Porto Rico 1
Totale 11.010
Città #
Singapore 831
San Jose 623
Hong Kong 312
Moscow 304
Beijing 256
Ashburn 253
Chandler 209
Napoli 176
Hanoi 170
Ho Chi Minh City 156
The Dalles 155
Santa Clara 129
Jacksonville 121
Naples 115
Princeton 112
Dallas 111
Amsterdam 104
Lauterbourg 101
Nanjing 98
Millbury 96
Boston 91
Los Angeles 81
Ottawa 68
Wilmington 63
Munich 54
Hefei 50
New York 50
Buffalo 49
Tokyo 48
Redondo Beach 39
São Paulo 32
Haiphong 29
Nanchang 25
Rome 25
Mexico City 24
Orem 23
Council Bluffs 22
Da Nang 22
Des Moines 22
Falls Church 21
Frankfurt am Main 21
Hebei 21
Milan 20
Norwalk 20
Dublin 19
Tianjin 19
Turku 19
Woodbridge 19
Helsinki 18
Montreal 17
Changsha 16
Pune 16
Chicago 15
London 15
Toronto 15
Chennai 14
Hicksville 14
Seattle 14
Shenyang 14
Brooklyn 13
Warsaw 13
Dong Ket 12
Nuremberg 12
Redwood City 12
Rio de Janeiro 12
Stockholm 12
Houston 11
Denver 10
Manchester 10
Palma Campania 10
Belo Horizonte 9
Boardman 9
Brasília 9
Formia 9
Jiaxing 9
Poplar 9
San Mateo 9
Thái Nguyên 9
Ann Arbor 8
Baghdad 8
Charlotte 8
Dhaka 8
Mumbai 8
Tashkent 8
Afragola 7
Bangkok 7
Biên Hòa 7
Curitiba 7
Florence 7
Hangzhou 7
Hải Dương 7
Kunming 7
Lappeenranta 7
Phoenix 7
Seoul 7
Thái Bình 7
Can Tho 6
Guarulhos 6
Kochi 6
Lahore 6
Totale 5.951
Nome #
Progetto dimostratore di analisi dei tessuti: BIONCAM BIObanca ONcologica CAMpania 263
Urokinase-type plasminogen activator receptor (uPAR) expression enhances invasion and metastasis in RAS mutated tumors 215
Impaired Seroconversion After Severe Acute Respiratory Syndrome Coronavirus 2 mRNA Vaccine in Patients With Thymic Epithelial Tumors 201
Epigenetic silencing of THY1 tracks the acquisition of the Notch1-EGFR signaling in a xenograft model of CD44+/CD24low/CD90+ myoepithelial cells 180
Metabolic and anthropometric changes in early breast cancer patients receiving adjuvant therapy 173
1599P - Effects of Hedgehog signaling inhibition on epithelial-stromal interactions in triple negative breast cancer cells 166
Everolimus induces Met inactivation by disrupting the FKBP12/Met complex 165
Src inhibitors act through different mechanisms in Non-Small Cell Lung Cancer models depending on EGFR and RAS mutational status 161
Toll-like receptor 9 agonist IMO cooperates with everolimus in renal cell carcinoma by interfering with tumour growth and angiogenesis. 154
Human epidermal growth factor receptor 2 dual blockade with trastuzumab and pertuzumab in real life: Italian clinical practice versus the CLEOPATRA trial results 145
The dual PI3K/mTOR inhibitor PKI-587 enhances sensitivity to cetuximab in EGFR-resistant human head and neck cancer models. 144
SPHINGOSINE KINASE 1 (SPHK1) CONTRIBUTES TO RESISTANCE TO EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) INHIBITORS IN COLORECTAL CANCER MODELS 140
P0081 Src inhibitors act through different mechanisms to cooperate with EGFR or MEK inhibitors in NSCLC models sensitive or resistant to erlotinib 139
Circulating and disseminated tumor cells from breast cancer patient-derived xenograft-bearing mice as a novel model to study metastasis. 137
Hedgehog signalling pathway orchestrates angiogenesis in triple-negative breast cancers 137
Exploring the molecular aspects associated with testicular germ cell tumors: A review 136
Exploring the interplay between Kaposi's sarcoma and SARS‐CoV‐2 infection: A case series and systematic review 135
Cells derived from normal or cancer breast tissue exhibit different growth properties when deprived of arginine. 132
Inhibition of Hedgehog signalling by NVP-LDE225 (Erismodegib) interferes with growth and invasion of human renal cell carcinoma cells 131
Epidermal growth factor receptor activation modulates Src-dependent resistance to lapatinib in breast cancer models. 129
Reti dinamiche di apprendimento a distanza 128
The Epithelial-Stromal Interaction as a Potential Target for Breast Cancer Treatment 126
The effect of the alpha-specific PI3K inhibitor alpelisib combined with anti-HER2 therapy in HER2+/PIK3CA mutant breast cancer 125
A banking strategy toward customized therapy in breast cancer. 124
Long-term cultures of stem/progenitor cells from lobular and ductal breastcarcinomas under non-adherent conditions. 123
Tranfected Insulin- like growth factor II modulates the mitogenic response of rat thyrocytes in culture 120
Combination of a Toll-like receptor 9 agonist with everolimus interferes with the growth and angiogenic activity of renal cell carcinoma. 119
Alterations of autophagy in the peripheral neuropathy Charcot-Marie-Tooth type 2B 118
Oral administration of a novel taxane, an antisense oligonucleotide targeting protein kinase A, and the epidermal growth factor receptor inhibitor Iressa causes cooperative antitumor and antiangiogenic activity. 114
Sphingosine Kinase 1 (SphK1) overespression contributes to cetuximab resistance in human colrectal cancer. 114
Combined inhibitory effect of formestane and herceptin on a subpopulation of CD44+/CD24low breast cancer cells. 113
Correction: Metabolic syndrome, endocrine disruptors and prostate cancer associations: biochemical and pathophysiological evidences 113
AIRC Regional Grant ; “Breast cancer: preclinical and clinical development of therapeutic strategies targeting molecular mechanisms”. 111
Enhancement of antitumor activity of ionizing radiation by combined treatment with the selective EGFR-tyrosine kinase inhibitor ZD1839 (‘Iressa’) 109
miRNAs in the Box: Potential Diagnostic Role for Extracellular Vesicle-Packaged miRNA-27a and miRNA-128 in Breast Cancer 108
Combined targeted inhibition of Bcl-2, Bcl-xL, EGFR and Protein Kinase A Type I causes potent antitumor, apoptotic and antiangiogenic activity 108
Zoledronic acid cooperates with a cyclooxygenase-2 inhibitor and gefitinib in inhibiting breast and prostate cancer. 107
Endogenous IGFs modulates the mitogenic response of rat thyrocites in culture. 106
Low doses of cisplatin or gemcitabine plus Photofrin/photodynamic therapy: Disjointed cell cycle phase-related activity accounts for synergistic outcome in metastatic non-small cell lung cancer cells (H1299). 106
Combination of a selective cyclooxygenase-2 inhibitor with epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 and protein kinase A antisense causes cooperative antitumor and antiangiogenic effect. 103
Expression of the soluble lectin L-14 gene is induced by TSH in thyroid cells and suppressed by retinoic acid in transformed neural cells. 103
Antitumor effects of ZD6474, a small molecule Vascular Endothelial Growth Factor receptor tyrosine kinase inhibitor, with additional activity against Epidermal Growth Factor. 99
INHIBITION OF CANCER CELL GROWTH AND INVASION BY TARGETING C-SRC IN BREAST CANCER MODELS RESISTANT TO ANTI-HER2 DRUGS 99
Adenosine 3',5'-monophosphate mediates both the mitogenic effect of thyrotropin and its ability to amplify the response to insulin-like growth factor I in FRTL5 cells. 96
Micrornas in prostate cancer: an overview 96
Combined targeted inhibition of Bcl-2, Bcl-xL, EGFR and Protein Kinase A Type I causes potent antitumor, apoptotic and antiangiogenic activity. 95
Iodine Inhibits the Proliferation of Rat-thyroid Cells In Culture 94
Inibizione della proliferazione: ruolo del cAMP. 93
ALTERATIONS OF AUTOPHAGIC FLUX IN CHARCOT-MARIE-TOOTH 2B DISEASE 89
“Pharmacogenetics and endocrine therapy in postmenopausal early breast cancer patients. Correlation study of gene CYP19 and CYP2D6 polymorphisms with efficacy and toxicity” 88
Condroitin-6-sulfate carbohydrate units. A major source of molecular microheterogeneity of human thyroglobulin. 88
ADE-SOCRATES- Sperimentazione di e-learning su un corso di Attività Didattica Elettiva della Facoltà di Medicina e Chirurgia di Napoli “Federico II”. In: Reti dinamiche di apprendimento a distanza, U. Giani ed. Liguori Editore, pp. 345-350, 2004. ISBN: 88-207-3637-3 87
Cytometric and biochemical characterization of human breast cancer cells reveals heterogeneous myoepithelial phenotypes 86
ANTITUMOR ACTIVITY OF THE COMBINATION OF CETUXIMAB, AN ANTI-EGFR BLOCKING MONOCLONAL ANTIBODY AND ZD6474, AN INHIBITOR OF VEGFR AND EGFR TYROSINE KINASES. 85
Pharmacogenetics and Endocrine therapy in postmenopausal early breast cancer patients. Correlation study of gene CYP19 and CYP2D6 polymorphisms with efficacy and Toxicity. 85
Ruolo di fattori di crescita autocrini nel controllo della proliferazione di cellule di tiroide di ratto in coltura. 84
Independent and Interactive Effects of Tetradecanoyl Phorbol Acetate On Growth and Differentiated Functions of Frtl5 Cells 83
Analysis of circulating extracellular vesicle derived microRNAs in breast cancer patients with obesity: a potential role for Let-7a 82
Antitumor effects of ZD6474, a small molecule vascular endothelial growth factor receptor tyrosine kinase inhibitor, with additional activity against epidermal growth factor receptor tyrosine kinase 82
Principi di Patologia Generale 81
Endogenous IGFs modulate the mitogenic response in rat thyrocites in culture. 81
Dissociation and reassociation of non-covalently linked dimers of human 19S thyroglobulin treated with urea. 80
Antitumor activity of ZD6474, a small molecule VEGF receptor tyrosine kinase inhibitor, in human cancer cells with acquired resistance to EGF receptor-targeted drugs. 79
Combination of a selective cyclooxygenase-2 inhibitor with epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 and protein kinase A antisense causes cooperative antitumor and antiangiogenic effect. 78
Combination of a selective cyclooxygenase-2 inhibitor with epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 and protein kinase A antisense causes cooperative antitumor and antiangiogenic effect. 78
Antitumor effects of ZD6474, a small molecule vascular endothelial growth factor receptor tyrosine kinase inhibitor, with additional activity against epidermal growth factor receptor tyrosine kinase. 77
Endogenous IGF-II as a possible regulator of fetal rat thyroid gland development. 77
Realizzazione e potenziamento di laboratori pubblici nei settori delle "scienze della nutrizione", "chirurgia avanzata" e "analisi dei tessuti". 76
Circulating and disseminated tumor cells from breast cancer patient 76
Growth control of follicular cells in vitro. 75
Increased bile acid excretion and reduction of serum cholesterol after crenotherapy with salt-rich mineral water 75
Iodine inhibits the proliferation of rat thyroid cells in culture. 72
Annual Meeting of the ECTS Medical Association 72
Iodine inhibits the proliferation of rat thyroid cells. 71
In the thyroid cells proliferation, differentiated and metabolic functions are under the control of different steps of the cyclic AMP cascade. 71
Evidence of a biological role of an endogenous growth factor on the proliferation of rat thyroid cells. 71
TSH-EGF cooperation in the FRTL5 thyroid cell growth stimulation. 71
The disulfide bond pattern between fragments obtained by the limited proteolysis of bovine thyroglobulin. 69
Iodine inhibits the proliferation of rat thyroid cells in culture. 69
On the role of iodine on the proliferation of FRTL5 cells. 69
Adenosine Has Divergent Effects On Deoxyribonucleic-acid Synthesis In Frtl5 Cells - Inhibition of Thyrotropin-stimulated and Potentiation of Insulin-like Growth Factor-i-stimulated Thymidine Incorporation 69
Role of DNA repair machinery and p53 in the testicular germ cell cancer: a review 69
IGF endogeno e proliferazione di tireociti. 68
Metabolic syndrome, endocrine disruptors and prostate cancer associations: biochemical and pathophysiological evidences 68
Expression of genes related to cell cycle in thyroid cells in culture. 67
Oncotech 67
Photodynamic therapy with indocyanine green complements and enhances low-dose cisplatin cytotoxicity in MCF-7 breast cancer cells. 66
In vitro expansion of human breast cancer epithelial and mesenchymal stromal cells: optimization of a coculture model for personalized therapy approaches. 65
Epidermal Growth-factor Modulation of Tsh Mitogenic Activity 65
Expression of the Soluble Lectin L-14 Gene Is Induced By Tsh In Thyroid-cells and Suppressed By Retinoic Acid In Transformed Neural Cells 65
The tissue-specific pathways regulating cell proliferation are inherited independently in somatic hybrid between thyroid and liver cells. 64
Studio GIM5: Studio di correlazione tra il gene CYP19 e l’efficacia di Letrozolo in pazienti in postmenopausa con tumore della mammella 64
Short-term and Long-term Effects of Egf On Frtl5 Cells Growth 64
SRC INHIBITORS ACT THROUGH DIFFERENT MECHANISMS TO COOPERATE WITH EGFR OR MEK INHIBITORS IN NSCLC MODELS SENSITIVE OR RESISTANT TO ERLOTINIB 64
Sustained versus transient cyclic AMP intracellular levels: effect on thyrotropin-dependent growth of thyroid cells. 63
Sustained versus transient cyclic AMP intracellular levels: Effect on thyrotropin-dependent growth of thyroid cells 62
Epithelial-mesenchymal transition in prostate cancer: an overview 62
Insights on the association of anthropometric and metabolic variables with tumor features and genomic risk in luminal early breast cancer: Results of a multicentric prospective study 61
Transfected insulin-like growth factor II modulates the mitogenic response of rat thyrocytes in culture. 60
Regolazione della proliferazione e delle funzioni differenziate in mutanti di cellule tiroidee TSH-indipendenti. 59
Totale 10.052
Categoria #
all - tutte 37.411
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.411


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022701 11 0 6 12 28 23 22 29 117 55 116 282
2022/2023605 124 43 20 23 65 60 2 51 72 106 28 11
2023/2024475 17 58 72 38 32 56 4 41 1 5 101 50
2024/20252.774 154 167 9 52 58 128 332 136 263 306 954 215
2025/20265.135 615 374 428 379 839 252 712 297 610 338 140 151
2026/202740 40 0 0 0 0 0 0 0 0 0 0 0
Totale 11.167